(Q30986400)

28 June 2017

Discovery of ligands by a combination of computational and NMR-based screening: RNA as an example target (English)

1 reference

28 June 2017

Moriz Mayer

1

1 reference

PubMed ID

15808238

28 June 2017

Thomas L James

series ordinal

2

1 reference

PubMed ID

15808238

28 June 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

28 June 2017

Methods in Enzymology

1 reference

28 June 2017

394

1 reference

28 June 2017

571-587

1 reference

Biased probability Monte Carlo conformational searches and electrostatic calculations for peptides and proteins

28 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

ICM?A new method for protein modeling and design: Applications to docking and structure prediction from the distorted native conformation

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

Integration of virtual and high-throughput screening

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

Saturation transfer difference NMR and computational modeling of a sialoadhesin-sialyl lactose complex.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

Protein-based virtual screening of chemical databases. 1. Evaluation of different docking/scoring combinations.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

Structure-based discovery of ligands targeted to the RNA double helix.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

Cross-linking in the Living Cell Locates the Site of Action of Oxazolidinone Antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

NMR-based screening technologies

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

The Ternary Complex of Cytochrome f and Cytochrome c: Identification of a Second Binding Site and Competition for Plastocyanin Binding

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

Identification of compounds with binding affinity to proteins via magnetization transfer from bulk water.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

WaterLOGSY as a method for primary NMR screening: practical aspects and range of applicability.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

A general NMR method for rapid, efficient, and reliable biochemical screening

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

Application and limitations of X-ray crystallographic data in structure-based ligand and drug design

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

Rational design of inhibitors of HIV-1 TAR RNA through the stabilisation of electrostatic "hot spots"

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

Proton nuclear magnetic resonance studies of the effects of ligand binding on tryptophan residues of selectively deuterated dihydrofolate reductase from Lactobacillus casei

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

The SHAPES strategy: an NMR-based approach for lead generation in drug discovery.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

Identification of ligands for RNA targets via structure-based virtual screening: HIV-1 TAR.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

A structure-based strategy to identify new molecular scaffolds targeting the bacterial ribosomal A-site

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

Structure of the A site of Escherichia coli 16S ribosomal RNA complexed with an aminoglycoside antibiotic

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

Paromomycin binding induces a local conformational change in the A-site of 16 S rRNA

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

Targeting RNA with small-molecule drugs: therapeutic promise and chemical challenges

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

Determinants of aminoglycoside-binding specificity for rRNA by using mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

Integration of NMR and high-throughput screening

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

Privileged molecules for protein binding identified from NMR-based screening

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

A Strategy for High-Throughput Assay Development Using Leads Derived from Nuclear Magnetic Resonance-Based Screening

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

Strategies for the Design of Drugs Targeting RNA and RNA-Protein Complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

Rational ligand design for RNA: the role of static structure and conformational flexibility in target recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

Chemical and functional diversity of small molecule ligands for RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

Inhibition of gene expression in human cells through small molecule-RNA interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

CORCEMA refinement of the bound ligand conformation within the protein binding pocket in reversibly forming weak complexes using STD-NMR intensities.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

Application of NMR SHAPES screening to an RNA target.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

Structure-based design and combinatorial chemistry yield low nanomolar inhibitors of cathepsin D.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

Evaluation of the FLEXX incremental construction algorithm for protein-ligand docking

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

Selective incorporation of 19F-labeled Trp side chains for NMR-spectroscopy-based ligand-protein interaction studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

Library design for NMR-based screening

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

Applications of SHAPES screening in drug discovery.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

Protein-ligand interactions: exchange processes and determination of ligand conformation and protein-ligand contacts

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

Structure-based computational database screening, in vitro assay, and NMR assessment of compounds that target TAR RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

Drug-like properties and the causes of poor solubility and poor permeability

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

Fluorescence-based methods for evaluating the RNA affinity and specificity of HIV-1 Rev-RRE inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

Biochemical and nuclear magnetic resonance studies of aminoglycoside-RNA complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

Comparison of X-ray crystal structure of the 30S subunit-antibiotic complex with NMR structure of decoding site oligonucleotide-paromomycin complex

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

Structure-based virtual screening: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

Detecting ligand binding to a small RNA target via saturation transfer difference NMR experiments in D(2)O and H(2)O.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

NMR-based characterization of phenothiazines as a RNA binding scaffold

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

Characterization of Ligand Binding by Saturation Transfer Difference NMR Spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

Inhibitors of protein-RNA complexation that target the RNA: specific recognition of human immunodeficiency virus type 1 TAR RNA by small organic molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

NMR spectroscopy techniques for screening and identifying ligand binding to protein receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

Binding of 5-fluorotryptamine to polynucleotides as a model for protein-nucleic acid interactions: fluorine-19 nuclear magnetic resonance, absorption, and fluorescence studies

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

Leveraging structural approaches: applications of NMR-based screening and X-ray crystallography for inhibitor design.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

Structure-based drug design targeting an inactive RNA conformation: exploiting the flexibility of HIV-1 TAR RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

The bulge region of HIV-1 TAR RNA binds metal ions in solution.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

Nuclear magnetic resonance-based approaches for lead generation in drug discovery.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

NMR and in silico screening

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

Detailed analysis of scoring functions for virtual screening

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

SAR by MS: a ligand based technique for drug lead discovery against structured RNA targets

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

Diversity screening versus focussed screening in drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

Structure-based screening and design in drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

Testing a flexible-receptor docking algorithm in a model binding site

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

Structure of the 30S ribosomal subunit

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

Discovery of aminoglycoside mimetics by NMR-based screening of Escherichia coli A-site RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2994024-X

7 January 2021

10.1016/S0076-6879(05)94024-X

Identifiers

DOI

1 reference

28 June 2017

1 reference

PubMed ID

15808238